NexturnBioscience Co. Ltd (089140) — Cash Flow Quality Index
NexturnBioscience Co. Ltd (089140) has a Cash Flow Quality Index of 11.02x as of September 2025. Operating cash flow of ₩4.51 Billion exceeds net income of ₩409.51 Million, indicating high earnings quality where cash backs reported profits. Explore NexturnBioscience Co. Ltd cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
NexturnBioscience Co. Ltd Cash Flow Quality Index (2007–2023)
Historical Cash Flow Quality Index for NexturnBioscience Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 089140 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for NexturnBioscience Co. Ltd (2007–2023)
Year-by-year earnings quality comparison for NexturnBioscience Co. Ltd. For live market cap and the full company financial profile, see NexturnBioscience Co. Ltd (089140) market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.20x | ₩-1.97 Billion | ₩9.68 Billion | ▼ -142.8% |
| 2019 | 0.48x | ₩2.74 Billion | ₩5.76 Billion | ▼ -72.6% |
| 2018 | 1.73x | ₩9.63 Billion | ₩5.55 Billion | ▲ +131.4% |
| 2017 | 0.75x | ₩5.08 Billion | ₩6.78 Billion | ▼ -7.5% |
| 2016 | 0.81x | ₩17.88 Billion | ₩22.05 Billion | ▼ -42.4% |
| 2015 | 1.41x | ₩1.92 Billion | ₩1.36 Billion | ▼ -11.4% |
| 2014 | 1.59x | ₩6.48 Billion | ₩4.08 Billion | ▲ +1584.5% |
| 2010 | 0.09x | ₩235.94 Million | ₩2.50 Billion | ▼ -89.6% |
| 2009 | 0.91x | ₩998.03 Million | ₩1.10 Billion | ▲ +98.4% |
| 2008 | 0.46x | ₩945.34 Million | ₩2.06 Billion | ▼ -45.0% |
| 2007 | 0.83x | ₩2.26 Billion | ₩2.71 Billion | — |